Pmv Pharmaceuticalsinc Stock Z Score
| PMVP Stock | USD 1.62 0.01 0.62% |
Pmv | Z Score |
Pmv PharmaceuticalsInc Company Z Score Analysis
Pmv PharmaceuticalsI's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
| |||||||
| |||||||
| |||||||
| |||||||
|
Pmv Z Score Driver Correlations
Understanding the fundamental principles of building solid financial models for Pmv PharmaceuticalsI is extremely important. It helps to project a fair market value of Pmv Stock properly, considering its historical fundamentals such as Z Score. Since Pmv PharmaceuticalsI's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Pmv PharmaceuticalsI's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Pmv PharmaceuticalsI's interrelated accounts and indicators.
Click cells to compare fundamentals
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
| Competition |
Based on the company's disclosures, Pmv PharmaceuticalsInc has a Z Score of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.
Pmv PharmaceuticalsI Current Valuation Drivers
We derive many important indicators used in calculating different scores of Pmv PharmaceuticalsI from analyzing Pmv PharmaceuticalsI's financial statements. These drivers represent accounts that assess Pmv PharmaceuticalsI's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Pmv PharmaceuticalsI's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 1.6B | 2.8B | 1.0B | 396.7M | 148.8M | 141.4M | |
| Enterprise Value | 1.7B | 2.4B | 881.4M | 302.4M | 123.6M | 117.4M |
Pmv PharmaceuticalsI Institutional Holders
Institutional Holdings refers to the ownership stake in Pmv PharmaceuticalsI that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Pmv PharmaceuticalsI's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Pmv PharmaceuticalsI's value.| Shares | Verition Fund Managegment, Llc | 2023-12-31 | 1.6 M | Bank Of America Corp | 2023-12-31 | 1.4 M | Partner Fund Management Lp | 2023-09-30 | 1.3 M | Oup Management Co., Llc | 2023-09-30 | 989.2 K | Octagon Capital Advisors Lp | 2023-09-30 | 904 K | Geode Capital Management, Llc | 2023-12-31 | 860.3 K | Acadian Asset Management Llc | 2023-12-31 | 768.4 K | Ghost Tree Capital, Llc | 2023-12-31 | 725 K | State Street Corporation | 2023-12-31 | 723.5 K | Orbimed Advisors, Llc | 2023-12-31 | 6.5 M | Jpmorgan Chase & Co | 2023-12-31 | 3.9 M |
Pmv Fundamentals
| Return On Equity | -0.29 | ||||
| Return On Asset | -0.19 | ||||
| Current Valuation | (106.95 M) | ||||
| Shares Outstanding | 51.44 M | ||||
| Shares Owned By Insiders | 2.94 % | ||||
| Shares Owned By Institutions | 99.54 % | ||||
| Number Of Shares Shorted | 2.6 M | ||||
| Price To Book | 0.41 X | ||||
| EBITDA | (78.88 M) | ||||
| Net Income | (68.96 M) | ||||
| Cash And Equivalents | 277.43 M | ||||
| Cash Per Share | 6.08 X | ||||
| Total Debt | 13.29 M | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 24.76 X | ||||
| Book Value Per Share | 4.39 X | ||||
| Cash Flow From Operations | (55.66 M) | ||||
| Short Ratio | 3.73 X | ||||
| Earnings Per Share | (1.44) X | ||||
| Price To Earnings To Growth | (0.31) X | ||||
| Target Price | 8.75 | ||||
| Number Of Employees | 63 | ||||
| Beta | 1.64 | ||||
| Market Capitalization | 82.82 M | ||||
| Total Asset | 252.15 M | ||||
| Retained Earnings | (310 M) | ||||
| Working Capital | 193.38 M | ||||
| Net Asset | 252.15 M |
About Pmv PharmaceuticalsI Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pmv PharmaceuticalsInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pmv PharmaceuticalsI using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pmv PharmaceuticalsInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Pmv PharmaceuticalsInc using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Pmv PharmaceuticalsI Piotroski F Score and Pmv PharmaceuticalsI Valuation analysis. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Complementary Tools for Pmv Stock analysis
When running Pmv PharmaceuticalsI's price analysis, check to measure Pmv PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pmv PharmaceuticalsI is operating at the current time. Most of Pmv PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of Pmv PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pmv PharmaceuticalsI's price. Additionally, you may evaluate how the addition of Pmv PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets |
Is Pmv PharmaceuticalsI's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pmv PharmaceuticalsI. If investors know Pmv will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pmv PharmaceuticalsI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.44) | Return On Assets (0.19) | Return On Equity (0.29) |
The market value of Pmv PharmaceuticalsInc is measured differently than its book value, which is the value of Pmv that is recorded on the company's balance sheet. Investors also form their own opinion of Pmv PharmaceuticalsI's value that differs from its market value or its book value, called intrinsic value, which is Pmv PharmaceuticalsI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pmv PharmaceuticalsI's market value can be influenced by many factors that don't directly affect Pmv PharmaceuticalsI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pmv PharmaceuticalsI's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pmv PharmaceuticalsI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pmv PharmaceuticalsI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.